Life Scientist > Lab Technology

Opinion: The need to back young scientisits

09 June, 2010 by Staff Writers

Australia’s research funding culture favours experienced scientists at the expense of promoting young researchers with great potential. Changes must be made if the future of Australian science is to be placed in safe hands.


Market Report: global rebound lifts Aussie biotechs

28 May, 2010 by David Binning

Australian biotechs rode a wave of renewed confidence in international markets this week which helped the local bourse to stage its best performance in weeks today. Investors were buoyed by news that China had rejected British media reports it was planning to reduce its European debt holdings, as well as generally improved sentiment towards Europe in the wake of the Greek financial crisis.


New approach to carbon storage could shift emissions battle

27 May, 2010 by David Binning

The UK’s Energy Technologies Institute ( ETI ) has announced a major new study to investigate and develop techniques for CCS ( carbon capture and storage ) based on mineralisation.


QIAGEN and Roche settle dispute

27 May, 2010 by Staff Writers

QIAGEN N.V.and Roche Molecular Systems Inc., a unit of Roche Holding AG ( ROG.VX ), have reached an out-of-court agreement ending a dispute over rights for a set of companion diagnostic products developed and manufactured by QIAGEN’s Manchester subsidiary DxS Ltd.


Australian Scientists elected to Royal Society

27 May, 2010 by David Binning

The Australian Academy of Science has announced that three local scientists have this year been elected as Fellows of Britain’s Royal Society, as the prestigious group celebrates its 350th anniversary.


Australian elected Fellow of the Royal Society

25 May, 2010 by David Binning

The CSIRO’s Dr Ezio Rizzardo has been elected as a Fellow of Britain’s Royal Society for his work in the area of polymers. This year celebrating its 350th anniversary, the Royal Society boasts some of history’s most influential minds among its alumni, including Isaac Newton, Charles Darwin, Benjamin Franklin and Stephen Hawking.


Xenome anoints new executive director

25 May, 2010 by David Binning

Brisbane-based biopharmaceutical company Xenome announced today its appointment of industry veteran Michael Aldridge as executive director.


NICTA's John Parker gets Clunies Ross gong

20 May, 2010 by Tim Dean

Dr John Parker, Chief Technology Officer at NICTA, has received a Clunies Ross Award for his work on the bionic ear at an exclusive black tie dinner in Melbourne last night.


PM's Science Prize nominations close this Friday

19 May, 2010 by Staff Writers

Friday May 21 is your final day to submit applications for the Prime Minister's Prizes for Science, so stop editing that PhD student's paper and get your entry in now.


Commentary: R&D tax credit bill punishes success, rewards failure

14 May, 2010 by Staff Writers

The final draft of the Government’s proposed revised R&D tax credit legislation was introduced into Parliament yesterday, less than 12 hours after it was made available to members of Parliament and the Australian business community.


Commentary: Persist with tax credit urges biotech

12 May, 2010 by Staff Writers

As time ticks down to get the new R&D tax credit bill through parliament by the 1 July implementation date, opposition from outside the biotech sector may seriously threaten its passage – and AusBiotech urges the Federal Government to persist.


Suzanne Cory to head Australian Academy of Science

11 May, 2010 by Tim Dean

One of Australia's most influential cancer researchers has taken over the reigns - or is that the gavel - of the Australian Academy of Science.


Asian biotechs love cloud computing

28 April, 2010 by Staff Writers

Cloud computing - where IT assets and raw computing power are outsourced over the internet - is rapidly growing in popularity, particularly amongst biotechnology companies in Japan, India and China, according to analysts, Ovum.


How to succeed in biotech: get the best people

27 April, 2010 by Tim Dean

Venture capital looks for three things in a biotechology company: people, people and people. So said Michael Quinn, managing partner at Innovation Capital, speaking at the inaugural Australian Life Scientist Roundtable discussion on Friday.


US continues push for public access to science

16 April, 2010 by Staff Writers

Fuelling the growing momentum toward openness, transparency, and accessibility to publicly funded information, the Federal Research Public Access Act of 2010 (FRPAA) has been introduced today in the US House of Representatives by Republican Mike Doyle (D-PA) and a bi-partisan host of co-sponsors.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd